G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 03/01/24
G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsGlobeNewsWire • 02/28/24
G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceGlobeNewsWire • 02/27/24
G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024GlobeNewsWire • 02/15/24
G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring CommitteeGlobeNewsWire • 02/12/24
G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/08/24
G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/24
G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer TherapyGlobeNewsWire • 12/05/23
G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer SymposiumGlobeNewsWire • 11/30/23
G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational HighlightsGlobeNewsWire • 11/01/23
Real World Data Indicate That Trilaciclib Reduces Hospitalizations and Myelosuppressive Events and May Improve Survival in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)GlobeNewsWire • 10/27/23
Will G1 Therapeutics (GTHX) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 10/25/23
G1 Therapeutics' COSELA® (trilaciclib) Recommended in Updated Small Cell Lung Cancer Guidelines from the American Society of Clinical Oncology (ASCO)GlobeNewsWire • 10/18/23
G1 Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 1, 2023GlobeNewsWire • 10/18/23
G1 Therapeutics Announces Upcoming Presentations at the 2023 ASCO Quality Care SymposiumGlobeNewsWire • 10/16/23
G1 Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceGlobeNewsWire • 09/05/23